Yeast super-suppressors are altered tRNAs capable of translating a nonsense codon in vitro. by Capecchi, Mario R. & Hughes, Stephen H.
Cell. Vol. 6, 269-277, November 1975, Copyright® 1975 by MIT
Yeast Super-Suppressors Are Altered tRNAs 
Capable of Translating 
a Nonsense Codon in Vitro




Salt Lake City, Utah 84112
Summary
tRNA isolated from two different yeast super-sup­
pressor strains translates a known nonsense muta­
tion in vitro, whereas tRNA from a closely related 
nonsuppressing strain does not. Suppression was 
assayed by translation of RNA isolated from an 
amber coat mutant of bacteriophage Q/3 (GB11) in 
a protein-synthesizing system derived from mouse 
tissue culture cells (L cells). Suppressed forms of 
Q/3 coat protein synthesized in vitro were quantita­
tively detected by a specific immunoprecipitation 
assay. The L-cell protein-synthesizing system also 
responds to E. coli suppressor tRNA. This indicates 
that the biochemical mechanism for nonsense sup­
pression is very similar in yeast and E. coli. These 
findings also provide additional evidence that the 
amber codon (UAG) functions as one of the mam­
malian chain-terminating codons. Since the sup­
pression assay utilizes protein-synthesizing compo­
nents isolated from mammalian cells, it should 
prove useful in the search for mammalian nonsense 
suppressors.
Introduction
The codons UAA (ocher), UAG (amber), and UGA 
(opal) serve as signals for polypeptide chain termi­
nation in bacteria (Brenner, Stretton, and Kaplan, 
1965; Weigert and Garen, 1965; Sambrook, Fan, 
and Brenner, 1967; Zipser, 1967). Recent studies 
suggest that these codons act as polypeptide chain 
termination signals in mammalian cells and yeast 
as well (Beaudet and Caskey, 1971; Martin, 1974; 
Stewart et al., 1972; Stewart and Sherman, 1972, 
1973). A class of mutations can be isolated in bacte­
ria, called nonsense mutations, in which a chain ter­
mination codon arises in the interior of a structural 
gene. Since polypeptide chain termination occurs 
at the site of the genetic alteration in such mutants, 
an amino terminal polypeptide fragment is pro­
duced by the affected gene.
In bacteria, nonsense mutations may be reverted 
by extragenic suppressors. These suppressors 
have been characterized and are known to be al­
tered tRNA molecules (Capecchi and Gussin, 1965; 
Engelhardt et al., 1965; Goodman et al., 1968). The 
suppressor tRNAs operate by inserting a specific 
amino acid at the nonsense codon, thereby allow­
ing completion of the polypeptide chain.
There are also mutations in yeast which are sup- 
pressible by a second unlinked mutation called a 
super-suppressor (Hawthorne and Mortimer, 1963, 
1968; Gilmore, Stewart, and Sherman, 1971; Sher­
man et al., 1973). Although the mode of action of 
the super-suppressors has not yet been directly ex­
amined, evidence suggests that some of the sup- 
pressible alleles are nonsense mutations. Analysis 
of the amino acid replacements in intragenic rever- 
tants of suppressible mutants of iso-1-cytochrome 
c have indicated that the mutants arose by alter­
ation of a wild-type codon to a UAA or UAG codon 
(Gilmore et al., 1971; Stewart and Sherman, 1972, 
1973; Stewart et al., 1972). Biochemical and genetic 
studies of suppressible mutations indicate that they 
can be polar (Manney, 1964; Fink, 1966) and, in 
some cases, that they may lead to the production 
of incomplete gene products (Manney, 1968; 
Shaffer, Rytka, and Fink, 1969). Furthermore, tyro­
sine and serine have been shown to be inserted 
in vivo at UAA or UAG codons by some super-sup­
pressor strains (Gilmore et al., 1971; Sherman et 
al., 1973; Liebman, Stewart, and Sherman, 1975; F. 
Sherman, personal communication). These are two 
of the amino acids inserted at nonsense codons by 
known bacterial nonsense suppressors (Weigert 
and Garen, 1965; Stretton and Brenner, 1965; No- 
tani et al., 1965; Weigert, Lanka, and Garen, 1965; 
Kaplan, Stretton, and Brenner, 1965). Thus the sup­
pressible alleles in yeast appear to be nonsense mu­
tations. These data are consistent with, but do not 
prove, the hypothesis that yeast super-suppressors 
operate by a mechanism similar to that of bacterial 
nonsense suppressors.
In this paper we demonstrate that tRNA isolated 
from two strains of yeast carrying different super­
suppressor mutations exhibits suppressor tRNA ac­
tivity in vitro. tRNA isolated from a nonsuppressing 
yeast strain shows no suppressor activity in vitro. 
The assay for detecting suppressor tRNA in yeast 
used a protein-synthesizing system derived from 
mouse L cells. It was programmed with RNA isolat­
ed from the bacteriophage Q/? or a derivatiVe of Q/? 
(GB11) which contains an amber mutation in the 
coat protein gene. The L-cell system recognizes the 
amber codon in GB11 RNA as a chain-terminating 
codon in vitro. Addition of E. coli suppressor tRNA 
results in the synthesis of intact coat protein mole­
cules. The system was therefore optimized for sup­
pression using E. coli suppressor tRNA. Gesteland 
and co-workers, using a different in vitro protein- 
synthesizing system, have reached similar conclu­
sions about the mechanism of nonsense suppres­
sion in yeast (R. Gesteland, personal commu­
nication).
There are no known examples of either nonsense 
mutations or nonsense suppressors in mammalian
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cells. The cell-free protein-synthesizing system de­
scribed in this paper should be useful in the search 
for mammalian suppressor tRNAs, since it uses only 
mammalian cell protein synthesis components and 
responds to known suppressor tRNAs.
Results
Synthesis of Q/3 Coat Protein in the Mammalian 
Cell-Free Extracts
To show that super-suppression in yeast is caused 
by altered tRNA molecules capable of translating 
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Figure 1. Synthesis of Q/3 Coat Protein by a Cell-Free Protein- 
Synthesizing System Derived from Mouse L Cells 
In vitro protein synthesis was performed and the reaction mixtures 
immunoprecipitated, washed, electrophoresed, and processed as 
described in Experimental Procedures. The arrows Indicate the po­
sition of migration of the fluoresceinated molecular weight markers 
cytochrome (left arrow, molecular weight 12,500 daltons) and 
myoglobin (right arrow, molecular weight 17,000 daltons). The 
fluoresceinated molecular weight markers migrate with their un­
labeled counterparts on SDS-urea gels (Hughes et al., 197S). Q/J 
coat protein has a monomer molecular weight of 14,000 daltons 
(Konigsberg et al., 1970). Each point on the graphs represents 
the radioactivity present in a 1 mM slice of the gel.
(A) shows the pattern of radioactivity on an SDS-urea PAG of a 
reaction (immunoprecipitated with anti-Q/3 coat serum) in which 
protein synthesis was done without adding Q/3 RNA. The endoge­
nous level of amino acid incorporation was 5 x 104 cpm. (B) shows 
the pattern of Immunoprecipitable radioactivity seen after adding 
0/3 RNA to the L-cell protein-synthesizing system. (C) shows the 
pattern of radioactivity obtained when the In vitro system is pro­
grammed with GB11 RNA (a mutant of Q/J containing an amber 
mutation in the coat protein gene). (D) is the same experiment 
as shown In (B), except that the immunoprecipitatlon reaction was 
done with serum from a rabbit which had not been immunized 
with Q/3 coat protein.
Man cell-free protein-synthesizing system sensitive 
to suppressor tRNAs. The cell-free system is pro­
grammed with RNA isolated from the bacteriophage 
Q/3 or a derivative of Q/3 (GB11) which contains an 
amber mutation (UAG) in the viral coat protein 
gene. Aviv et al. (1972), Schreier et al. (1973), and 
Morrison and Lodish (1973, 1974) have shown that 
Q/3 coat protein is one of the polypeptide products 
synthesized in mammalian cell-free extracts pro­
grammed with QjB RNA.
We have increased the sensitivity of the assay for 
Q/8 coat protein synthesized in such mammalian 
cell-free systems by preparing an antibody directed 
against purified viral coat protein. Q/8 coat protein 
synthesized in vitro was selectively and quantitative­
ly immunoprecipitated by this antibody (see Experi­
mental Procedures). The immunoprecipitates were 
then analyzed by sodium dodecyl sulfate-urea 
polyacrylamide gel (SDS-urea PAG) electrophore­
sis. The gels were internally calibrated with fluo- 
rescenated protein molecular weight markers 
(Hughes, Wahl, and Capecchi, 1975). The specific 
antibody reaction provides further evidence for the 
synthesis of Q/3 coat protein in such cell-free sys­
tems. Figure 1B shows that mouse L-cell extracts 
programmed with Q/8 RNA synthesize a protein 
product which reacts with anti-Q/3 coat protein 
serum and has the same molecular weight as Q/3 
coat protein. No such material is synthesized in the 
extracts without added Q/3 RNA (A), nor is any such 
material synthesized in response to Q/3 RNA con­
taining an amber mutation in the viral coat protein 
cistron (C). The specificity of the antibody reaction 
is illustrated in the control experiment shown in Fig­
ure 1D. This panel demonstrates that Q fi coat pro­
tein synthesized in vitro is not precipitated by a non- 
immune serum. We can conclude from these 
experiments that Q/3 coat protein is synthesized in 
these mammalian cell-free extracts. The low back­
ground in the controls permits detection of very 
small amounts of Q/3 coat protein (■ v io - '5 moles).
The System Responds to E. coli Suppressor 
tRNA
Figure 2C shows that addition of partially purified
E. coli suppressor tRNA (isolated from a strain con­
taining an Su 1 suppressor gene, that is, Su+) to 
the mammalian cell-free system programmed with 
GB11 RNA allows synthesis of complete coat pro­
tein molecules. Figure 2B demonstrates that identi­
cally purified tRNA from the isologous E. coli strain 
lacking the S u  1 suppressor gene (S u -) fails to per­
mit the synthesis of coat protein. This mammalian 
cell-free system therefore responds to suppressor 
tRNA. These experiments imply that the amber 
codon (UAG) functions in mammalian cells in an 
analogous fashion to its role in bacterial systems
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(that is, as a polypeptide chain termination signal). 
Figure 3 shows that the addition of increasing 
amounts of purified E. coli suppressor tRNA results 
in increasing levels of suppression. This indicates 
that there is a competition between the suppressor 
tRNA and the mammalian polypeptide chain termi­
nation machinery for the UAG codon. These experi-
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Figure 2. Suppression ot the Amber Coat Mutant GB11 in a Mam­
malian Cell-Free Extract by E. coll Suppressor tRNA 
L-cell extracts were programmed with GB11 RNA. The reactions 
were immunoprecipitated, electrophoresed, and processed as de­
scribed in Experimental Procedures. The arrows represent the po­
sition of migration of the fluoresceinated molecular weight markers 
cytochrome c (left arrow, molecular weight 12,500 daltons) and 
myoglobin (right arrow, molecular weight 17.000 daltons).
(A) shows the pattern of immunoprecipitable radioactivity from an 
in vitro protein synthesis reaction programmed with GB11 RNA.
(B) shows the pattern of immunoprecipitable radioactivity from an 
identical reaction to that in (A), to which 20 fig of fractionated 
S26 tRNA (see Experimental Procedures) were added. S26 is a 
suppressor negative strain. (C) is as (B). except that the 20 pg 
of fractionated tRNA were isolated from S26RIE. a strain which 
contains Su 1 suppressor tRNA. S26 and S26RIE are isologous 
strains except for the suppressor gene. The tRNA used in the ex­
periments shown in (B) and (C) was prepared identically, and the 
corresponding fractions were used.
ments also provide an assay for detecting suppres­
sor tRNAs isolated from other cell sources, such 
as yeast or mammalian cells.
Yeast Super-Suppressor Strains Contain 
Suppressor tRNAs
Experiments analogous to those described above 
were performed to test the hypothesis that yeast 
super-suppressors contain altered tRNA molecules 
capable of translating nonsense codons. tRNA was 
isolated from a yeast super-suppressing strain 
(D599-4B) which contains the SUP7-2 suppressor 
gene. This strain inserts tyrosine at UAG codons 
in vivo (Sherman et al., 1973). The tRNA was frac­
tionated by benzoylated DEAE cellulose (BD cellu­
lose) chromatography, and the tyrosine-accepting 
fractions were pooled. The experiment illustrated in 
Figure 4 shows that this tRNA fraction is capable 
of suppressing the UAG codon in GB11 RNA. Fig­
ure 4B demonstrates that the same tRNA fraction 
from the closely related yeast strain (SL110) which 
does not contain a super-suppressor gene fails to 
permit synthesis of intact coat protein molecules. 
These experiments demonstrate that the super­
suppressor strain D599-4B contains altered tRNA 
molecules capable of translating the amber codon 
in the GB11 coat protein cistron.
Figure 5 shows the optical density profile of the 
D599-4B tRNA eluted from the BD cellulose column.
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Figure 3. Suppression of the Amber Coat Protein Mutant GB11 
with Increasing Amounts of Su 1 (E. coli) tRNA 
L-cell extracts were programmed with GB11 RNA, and the reac­
tions immunoprecipitated, electrophoresed. and processed as de­
scribed in Experimental Procedures. For the experiments shown 





The tRNA was pooled into three fractions as indicat­
ed on the graph. The tyrosine-accepting specific 
activity of each fraction was determined and is 
given in Table 1. Figure 6 indicates that fraction III 
contains the highest tyrosine-accepting specific ac­
tivity and also the highest suppressor specific activi­
ty. Fraction 1 of the D599-4B tRNA. which had a 
very low tyrosine-accepting specific activity, con­
tained no detectable suppressor tRNA activity. 
Each fraction of the D599-4B tRNA has been mea­









Figure 4. Suppression of the Amber Mutation in GB11 RNA by 
Yeast SUP7-2 tRNA
L-cell extracts were programmed with 60 ng of GB11 RNA. Reac­
tions were immunoprecipitated with anti-Q/i coat sera, electro- 
phoresed, and processed as described in Experimental 
Procedures.
(A) shows the immunoprecipitable radioactivity from a control ex­
periment with no added tRNA. (B) shows the same reaction with 
the addition of 20 /ig of BD cellulose-fractionated tRNA (see Experi­
mental Procedures) isolated from the nonsuppressing strain SL- 
110. (C) shows the immunoprecipitable radioactivity synthesized 
when 20 ng of fractionated tRNA isolated from the super- 
suppressing yeast strain D599-4B (SUP7-2-containing) were added 
to the reaction mixture. The tRNA from SL-110 and D599-4B was 
prepared identically, with analogous fractions used for the experi­
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tRNA concentrations (data not shown). For the ex­
periments shown in Figure 6, an equal amount of 
tRNA (OD2a0) from each fraction was added to the 
reaction mixtures. Since the suppressor tRNA activ­
ity chromatographs with the tyrosine acceptor ac­
tivity, these experiments are consistent with the 
hypothesis that the suppressor tRNA arose from an 
altered tyrosyl tRNA. In vitro suppression was not











Fraction I 3 29
Fraction II 33 62
Fraction III 100 100
Fraction IV 87
Relative amino acid acceptor activity in the benzoylated DEAE cel­
lulose fractions of tRNA isolated from super-suppressing yeast
strains.
The tRNAs were fractionated on benzoylated DEAE cellulose as 
shown in Figures 5 and 7. tRNA charging assays were done as 
described In Experimental Procedures. Specific activity of tRNA 
charging was normalized to the tRNA fraction containing the high­
est in vitro suppressor activity.
Fraction No.
Figure 5. Fractionation of D599-4B tRNA by Benzoylated DEAE 
Cellulose chromatography
285 mg of purified tRNA from D599-4B (a SUP7-2-containing strain) 
were loaded onto a 1.4 cm x  50 cm column of BD cellulose in 
25 mM Tris-CI (pH 7.4), 10 mM MgCI2, 1 mM DTT. The column 
was washed with 200 ml of this buffer, followed by 200 ml of 25 
mM Tris-CI (pH 7.4), 10 mM MgCI2, 200 mM NaCI, and 1 mM DTT. 
The tRNA was eluted In two steps. The first wash, which removed 
"'-80% of the tRNA bound to the column, was 25 mM Tris-CI (pH
7.4), 10 mM MgCI2, 200 mM NaCI, 1 mM DTT (pH 7.4). The remain­
ing ^20%  of the tRNA, containing most the suppressor activity 
(see Table 1), was eluted with 150 ml of 25 mM Tris-CI, 10 mM 
MgCI2, 1.1 m NaCI, 10% methoxyethanol, 1 mM DTT (pH 7.4). tRNA 
was pooled into fractions as shown by the arrows.
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observed with tRNA prepared from the nonsup­
pressing strain SL110, either before fractionation 
on BD cellulose or with the fractions obtained after 
BD cellulose chromatography (data not shown).
Figures 7 and 8 show analogous experiments 
using a different super-suppressing yeast strain 
(L374). This strain contains the SUQ5-2 suppressor 
gene which inserts serine at UAG codons in vivo 
(F. Sherman, personal communication). The L374 
tRNA was fractionated on a BD cellulose column 
and pooled into four fractions, as illustrated in Fig­
ure 7. Table 1 shows the relative serine-accepting 
specific activity for each of these fractions. Figure 
8 demonstrates that the SUQ5-2 strain does contain 
tRNA capable of translating the UAG codon in GB11 
RNA. In addition, the suppressor-specific activity 
correlates well with the serine-accepting specific 
activity. These results suggest that the SUQ5-2 sup­








Figure 6. In vitro Suppression with Benzoylated DEAE Fractions 
of tRNA from the SUP7-2-Contalning Yeast Strain D599-4B 
Fractions obtained in Figure 5 were assayed for suppressor activity 
as described in Experimental Procedures. (A) shows the pattern 
of counts from a control experiment in which no tRNA was added 
to the mammalian In vitro protein-synthesizing system programmed 
with GB11 RNA. The experiments shown in(B). (C), and (D) used 
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Figure 7. Fractionation of L-374 (SUQ5-2) tRNA by BD Cellulose 
Column Chromatography
249 mg of purified L-374 were prepared and loaded onto the ben­
zoylated DEAE cellulose column as described for the D599-4B 
tRNA (see Figure 5). The tRNA was eluted In three steps. The 
first wash was with 200 ml of 25 mM Tris-Cl (pH 7.4), 10 mM 
MgCIi, 650 mM NaCl, 1 mM DTT. This was followed by 200 ml 
of 25 mM Tris-Cl, 10 m MgCI2, 1.1 M NaCl, 1 mM DTT (pH 7.4). 
The final elution was with 200 ml of 25 mM Tris-Cl (pH 7.4), 10 
mM MgClj, 1.1 M NaCl, 10% methoxyethanol, 1 mM DDT (pH 7.4). 







Figure 8. In Vitro Suppression with Benzoylated DEAE Fractions 
of tRNA Isolated from the SUQ5-2-Containing Yeast Strain L-374 
The tRNA fractions are those shown in Figure 7. The assay for 
suppressor activity is as described in Experimental Procedures and 
Figure 1. (A) is the pattern of immunoprecipitable radioactivity on 
an SDS-urea polyacrylamide gel of the control experiment without 
added tRNA. (B) is the experiment with 20 ng of fraction i tRNA. 
(C) shows 20 fig of fraction II tRNA, (D) 20 /ig of fraction III tRNA, 





The data presented in this paper cannot be used 
to calculate the in vivo efficiency of suppression for 
two reasons. First, these experiments were per­
formed over an extended time period and used dif­
ferent mouse L-cell extracts. The different extracts 
varied in their ability to translate Q/3 RNA. Since this 
ability was measured for each extract, the data 
could be normalized for this parameter. A more 
serious difficulty is determining the degree of purity 
of the suppressor tRNA species. In theory, using 
pure suppressor tRNA, we should be able to ap­
proach 100% suppression in the cell-free system 
simply by adding increasing amounts of suppressor 
tRNA. 100% suppression is defined to mean the 
synthesis of as much Q/3 coat protein by the L-cell 
system programmed with GB11 RNA and suppres­
sor tRNA as is synthesized with Q/3 RNA. (The effi­
ciency of suppression could not be calculated by 
measuring the amount of amino terminal fragment 
produced relative to suppressed coat protein be­
cause the fragment is degraded in this system.) 
Very high levels of suppressor tRNA should com­
pete out the polypeptide chain termination ma­
chinery at the appropriate nonsense codons. In 
practice, the saturating levels of suppression ob­
served in the heterologous system are less than 
100%. Using the E. coli suppressor tRNA purified 
on BD cellulose (Gilham et al., 1967) and RPC-5 
(Pearson, Weiss, and Kelmers, 1971), we observe 
saturation at approximately 60% suppression. Addi­
tion of more tRNA results in inhibition of amino acid 
incorporation and reduced levels of detectable Q/3 
coat protein (data not shown). With the yeast sup­
pressor tRNAs fractionated by BD cellulose chro­
matography, we observe saturation at approxi­
mately 15% suppression. Again, the addition of 
more tRNA results in inhibition of translation and 
decreased levels of Q/3 coat protein synthesis. 
These experiments indicate that the tRNA fractions 
contain an inhibitor. It is reasonable to suspect that 
the inhibitors are tRNA molecules, since we are 
working with a heterologous system (that is, E. coli 
or yeast tRNA in a mammalian cell-free protein- 
synthesizing system).
Discussion
Our data demonstrate that the super-suppressors 
in yeast (Saccharomyces cerevisiae) and the non­
sense suppressors in bacteria act by a similar bio­
chemical mechanism. Both of the super-suppressor 
strains D599-4B (SUP7-2) and L374 (SUQ5-2) were 
shown to contain tRNA molecules capable of trans­
lating in vitro the amber (UAG) codon in the coat 
protein ciston of the mutant Q/3 phage GB11. tRNA 
from the closely related nonsuppressing strain SL-
110 does not suppress GB11 in vitro. Previous work 
has shown that the strains D599-4B (SUP7-2) and 
L374 (SUQ5-2) insert tyrosine and serine, respec­
tively, at UAG codons in vivo (Sherman et al., 1973;
F. Sherman, personal communication). The tRNA 
isolated from D599-4B was fractionated by chroma­
tography on a benzoylated DEAE cellulose column. 
The suppressing activity from D599-4B is coincident 
with the tyrosine-accepting tRNA fraction (Table 1). 
L374 (SUQ5-2) tRNA was also fractionated on ben­
zoylated DEAE cellulose. The suppressor activity 
chromatographs with the serine-accepting tRNA 
fractions. This suggests that SUP7-2 was derived 
from a tyrosyl tRNA and that SUQ5-2 was derived 
from a seryl tRNA.
The cell-free protein-synthesizing system used in 
these experiments was prepared from mouse tissue 
culture cells (L cells). This system, when pro­
grammed with GB11 RNA, responds to E. coli Su
1 suppressor tRNA. This directly relates the sup­
pression observed in vitro with yeast tRNA to the 
well characterized nonsense suppressors of E. coli.
The conditional lethal system provided by non­
sense mutations and their suppressors has been 
extremely valuable for genetic and biochemical 
analysis of bacteria and yeast. Development of a 
nonsense mutant suppressor system in cultured 
mammalian cells and their viruses should also be 
very useful. First, it would provide a nonleaky condi­
tional lethal system for genetic analyses. Because 
of the narrow temperature range over which mam­
malian cell lines can be propagated, tempera­
ture-sensitive mutations often exhibit partial activity 
at the nonpermissive temperature. Second, the 
nonsense mutant system can provide a direct 
means of identifying the mutant gene product. In 
a nonsuppressing cell line, the nonsense mutation 
would cause an amino terminal fragment to be pro­
duced from the affected gene.
Since the suppression assay employed in these 
experiments used a protein-synthesizing system 
derived from mouse L cells, it should be compatible 
with mammalian suppressor tRNAs. The demon­
stration that yeasts can tolerate nonsense suppres­
sors indicates that it is reasonable to seek such sup­
pressors in mammalian tissue culture cells. In 
addition, it is now clear that, at least in vitro, a mam­
malian protein-synthesizing system is capable of 
nonsense suppression if provided with an appropri­
ate tRNA and message.
Experimental Procedures 
Materials
RPC-5 was obtained from Astro Enterprises. Benzoylated DEAE 
cellulose, ,4C-tyroslne (460 mCi/mmole), !H-leucine (50 
Ci/mmole), and »H-lysine (47 Ci/mmole) were purchased from 
Schwarz-Mann. uC-serine (153 mCi/mmole) was obtained from
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New England Nuclear. ATP, GTP, CTP. pyruvate kinase (PK), and 
creatine phosphokinase (CPK) were purchased from Calblochem. 
Triton X-100 was the product of Rohm and Haas Co. (Philadelphia, 
Pennsylvania). Acrylamide and N.N' methylene bisacrylamide were 
obtained from Eastman Kodak. Ultra-pure SDS was purchased 
from the Pierce Chemical Co. (Rockford, Illinois). Freund's com­
plete adjuvant was obtained from Miles. The purified Oft coat pro­
tein used to prepare antiserum was a gift from Dr. A. Wiener. The 
coat protein was prepared from purified virus by chromatography 
on a DEAE-urea column. Phenol was redistilled before use and 
stored In the dark at -20°C .
Cells and Strains
The mouse tissue culture cells (L cells) used to prepare the cell-free 
extracts have been previously described (Sharp. Capecchi, and 
Capecchi, 1973). The yeast strains D599-4B, L374, and SL110 were 
supplied by Dr. F. Sherman. D599-4B contains the amber super­
suppressor SUP7-2. This strain was cloned on minimal agar (Man- 
ney, 1964), supplemented with histidine, leucine, and lysine. D599- 
4B also contains the Tyr7-1 and Trp1-1 alleles which are 
suppressed by SUP7-2. The cells were grown at 30°C in a broth 
culture containing 1% yeast extract, 2% peptone, and 3% dextrose 
(YEPD). For preparation of yeast tRNA, the cells were grown in 
1 0 1 cultures and harvested at 10 g /1. In YEPD medium, theSUP7-2- 
containing cells grow more slowly than cells which have lost the 
suppressor activity. We therefore plated out the cells just before 
harvesting to measure the ratio of suppressor-containing to sup­
pressor negative cells. More than 80% of the cells used for isolation 
of SUP7-2 tRNA exhibited suppressor activity, as demonstrated 
by their ability to grow on the appropriate agar plates.
L-374, which contains the amber super-suppressor SUQ5-2 and 
is <//* (Cox, 1965), was also cloned on histidine-, leucine-, and 
lysine-containing minimal agar plates. This strain contains the 
SUQ5-2 suppressible alleles m et8-1, trp1 -1 , and tyr7—1. Cells were 
grown as described for D599-4B. More than 95% of the L-374 cells 
used to prepare the tRNA still retained the SUQ5-2 suppressor 
gene when the culture was harvested. SL-110, which does not 
contain a super-suppressor, was grown from a single colony picked 
from YEPD agar plates. E. coli strains containing suppressors were 
routinely tested with bacteriophage \  and T4 tester strains to en­
sure that they retained the appropriate suppressing activity. E. coli 
strains were grown In broth containing 0.2 g MgCl26HjO, 1.98 g 
(Nm hSO., 2.72 g KH3PO4. 14 g KjHPO«, 4 g vitamin-free casamino 
acids (Difco), and 10 g of glucose per liter. Cells were harvested 
at 5 g /l. All tRNAs isolated from suppressor-containing E. coli 
strains were shown to contain suppressor activity in an E. coli 
in vitro protein-synthesizing system (Capecchi, 1966). Oft and 
GB11 (a derivative of Oft containing an amber mutation in the coat 
protein gene) were provided by Dr. P. Kaesberg. Oft and GB11 
were grown on S26 and the isogenic Su 7-containing strain 
S26RIE.
Preparation of Q/3 and GB11 RNA
Oft and GB11 were grown and purified according to the procedure 
of A. Wiener (1973). RNA was extracted from purified phage with 
distilled phenol as described by Capecchi (1966).
tRNA Preparation
tRNA was prepared from yeast and E. coli according to the meth­
ods of Capecchi (1966) with the following modifications. tRNA was 
extracted from freshly harvested cells at 4°C  using 1 vol (per weight 
of cells) of phenol and 1 vol of 50 mM NaHjPOj (pH 7.0). 1 mM 
dithiothreitol (DTT). For yeast tRNA, SDS was added to the extrac­
tion buffer to give a final concentration of 1%. The tRNA samples 
were purified by extraction with 1 M NaCI containing 1 mM DTT, and 
DEAE cellulose chromatography (Capecchi, 1966). The purified 
tRNA samples were fractionated on benzoylated DEAE cellulose 
according to Gilham et al., 1967. The Su 7-containing tRNA fraction 
purified by benzoylated DEAE cellulose chromatography of S2 6 RIE
tRNA was further purified by chromatography on RPC-5 (Pearson 
et al., 1971). S26 tRNA was prepared and purified In an identical 
manner so that analogous fractions of tRNA could be obtained 
from the nonsuppressing cell line.
Assays of tRNA Acceptor Activity
Each 50 jil assay for serine or tyrosine tRNA acceptor activity con­
tained 5 pi of an appropriate dilution of tRNA, Tris-HCI (pH 7.4) 
(67.5 mM), KCI (108 mM), MgCIi (4.5 mM), EDTA (0.45 mM), BSA 
(1 mg/ml), ATP (1.6 mg/ml), yeast S-300 (supernate from a 
300,000 x  g centrifugation, 4 mg protein/ml), PEP (5 mM), 
PK (2.7 I.U/ml), DTT (1.8 mM), '*C-serine (1.8 (iCI/ml). or ,4C -  
tyrosine (1.26 jiCI/ml). For each assay a range of tRNA concentra­
tions (10-50 jxg/50 pi reaction) was tested to ensure that the mea­
sured acceptor activity was within the linear range.
Preparation of Antisera
Two 10 lb male New Zealand white rabbits were injected su­
prascapularly at weekly intervals with 1.5 mg of purified Oft coat 
protein. The coat protein was suspended in 1 ml of 50 mM Tris-HCI 
(pH 7.4), 7 mM MgClj, and then an emulsion was made with 1 
ml of Freund's complete adjuvant. After 6 weeks of injections, the 
animals were bled and titered by precipitation of radioactive Q/3 
coat protein synthesized In vitro. One rabbit showed a response. 
After a 6 week rest, injections were resumed on a weekly basis. 
Blood (approximately 50 ml) was collected from the ear veins every 
2 weeks. When the titer reached a plateau level, the serum was 
used for the detection of Q/3 coat protein synthesized in vitro. Anti­
sera were processed and purified by (NH4)jS04  fractionation as 
previously described (Wahl, Hughes, and Capecchi, 1975).
Immunoprecipitation and Gel Electrophoresis
The in vitro protein-synthesizing reactions were analyzed for Q/3 
coat protein by quantitative immunoprecipitation with anti-Q/3 coat 
serum followed by electrophoresis of the precipitate on calibrated 
SDS-urea polyacrylamide gels (Hughes et al., 1975). 5 mg of anti­
body directed against purified Q/3 coat protein were added to each 
100 pi L-cell reaction mixture. After reacting overnight at 4°C, 10 
mg of goat anti-rabbit gammaglobulin were added and allowed to 
react for 4 hr at 4°C. The resulting precipitate was collected by 
centrifugation for 30 min at 1000 x  g. The pellets were washed 
twice at 4°C with 400 /»l of buffer containing 25 mM Tris-HCI (pH
7.4), 3.5 mM MgCI2, 300 mM KCI, 2% Triton X-100, and once with 
buffer containing 50 mM Tris-HCI (pH 7.4), 7 mM MgCi2 The pellet 
was recovered after each wash by centrifugation at 1000 x  g for 
30 min. Resuspension of the pellet in SDS-urea buffer, electro­
phoresis of the sample on SDS-urea polyacrylamide gels, and pro­
cessing of the gels for analysis of radioactivity have been previously 
described (Hughes et al., 1975). The only modification in these ; . 
studies is the use of 15% Instead of 11.1% polyacrylamide gels. 
Each gel was internally calibrated with fluoresceinated m y o g tw n ^  
and cytochrome c (Hughes et al., 1975).
Quantitative Immunoprecipitation of Q/3 Coat Pro,el!?i
In developing the immunoprecipitation assay form »- 
In vitro synthesized Q/3 coat in the L-cell extracts, tw 
required: the immunoprecipitation had to be quan 
serum should recognize in vitro Qfi 
number of different amino acid substitutions arjn«* 
mutation in GB11 (position 17). Both g&j&gW 
tested using an E. coli p ro te in ^ y n th e s r^ ^ *  
free extracts programmed with Ofi 
predominant protein synthesized;J rH || ! j  
rylamide gel electrophoretic analy" 
product and Immunoprecipitable^ ' 
tions: the reaction programmed •" 
reaction programmed with Gg$ 
tyrosyl suppressor tRNA (Su 
in Figure 9 that the immurr
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wild-type coat protein (which contains glutamine at position 17) 
and GB11 suppressed coat (which contains tyrosine at position 
17). We have also demonstrated that the GB11 coat with serine 
inserted at the amber site is quantitatively immunoprecipitated 
(data not shown). These experiments demonstrate that the antisera 
can be used to quantitatively precipitate suppressed forms of Q/3 
coat.
It Is interesting that GB11 will not form plaques on an Su 3 
(tyrosine-inserting) strain (data not shown). This is not a problem 
of efficiency of suppression, since an Su 1 strain (serine-inserting) 
which has a lower level of suppression than Su 3 (Garen, 1968) 
nevertheless is a permissive host for GB11. This leads to the con­
clusion that active phage cannot be formed with tyrosine at position 
17 of the coat protein, but that at least some of the antigenic deter­
minants are still present
L-Cell Extracts
Mouse L cells were grown in spinner culture (8 I) to a density 
of 5 x  10s cells per ml and harvested by centrifugation at 4°C  
for 10 min at 160 x  g. The cells were then washed 2 times with 
150 ml of buffer containing 35 mM Tris-HCl (pH 7.4), 146 mM NaCl.
Fraction No.
and 11 mM glucose. The washed cells were resuspended in 20 
ml of buffer containing 10 mM Tris-HCl (pH 7.4), 1.5 mM MgCI2, 
15 mM KCI, and 2 mM DTT. The cells were allowed to swell for 
10 min at 4°C, and then were broken by 30 strokes in a tightly 
fitting Dounce homogenizer. 2.5 ml of buffer containing 200 mM 
Hepes (pH 7.2), 30 mM MgClj, 1 M KCI. and 20 mM DTT were 
added to the crude homogenate. The cell homogenate was clarified 
by centrifugation at 20,000 x  g for 30 min. To reduce the en­
dogenous level of protein synthesis, the supernatant was incu­
bated at 32°C for 30 min In the presence of 2 mM ATP, 0.2 mM 
GTP, 7.5 mM creatine phosphate (CP), and 100 pg of creatine 
phosphokinase. After the incubation, the reaction mixture was cen­
trifuged at 1000 x  g for 20 min and chromatographed on a 300 
ml G25 Sephadex column. The macromolecular fractions were 
pooled and concentrated by dialysis against 2L of 20 mM Hepes 
(pH 7.2), 3 mM MgCI2, 100 mM KCI, 2 mM DTT, and 15% polyethy­
lene glycol (Union Carbide).
Mammalian Cell-Free Protein-Synthesizing System
A standard 100 pi reaction mixture contained 50 mM Hepes (pH 
7.2), 3.5 mM MgClj, 90 mM KCI, 2 mM ATP, 0.6 mM GTP, 12.5 
mM CP, 6 pg CPK, 40 pM of each amino acid except lysine and 
leucine, 2 mM DTT, 2.5 pCi of 3H-leucine, 2.5 pCi of 3H-lysine, 
60 pi of L-cell extract (prepared as described above), and, unless 
otherwise stated, 60 pg of either Q/3 RNA or GB11 RNA. The amount 
and type of tRNA added to the reaction mixtures are indicated 
in the figure legends. The reaction mixtures were Incubated at 33°C  
for 45 min. At the end of the incubation, the reaction was terminated 
by dilution with an equal volume of ice cold buffer (0°C) containing 
50 mM Hepes (pH 7.2) and 3 mM MgCl2. The reactions were then 
reacted with anti-Q/3 coat serum as described in Immunoprecipita- 
tion and Gel Electrophoresis.
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Figure 9. Immunoprecipitation and TCA Precipitation of Q/3 Coat 
Protein Synthesized in Vitro
E. coli extracts were programmed with Q/3 or GB11 RNA, and pro­
tein synthesis carried out as described by Capecchi (1966). After 
incubation at 36°C for 30 min, the reactions were divided Into two 
equal aliquots, one of which was immunoprecipitated as described 
in Experimental Procedures. 150 pi of 1 M NaOH were added to 
the other, followed by 2 ml of 7% TCA. TCA precipitates were col­
lected by centrifugation, the pellets resolubilized in 1 M NaOH, 
and then reprecipitated with 2 ml of 7% TCA. The precipitates were 
collected by centrifugation, the pellets washed twice with ice cold 
ether-ethanol (2 vol:1 vol), and dried with a stream of nitrogen. 
The pellets were then dissolved in loading buffer, electrophoresed, 
and the gels analyzed as described In Experimental Procedures. 
(A) shows the electrophoretic pattern obtained from an E. coli reac­
tion mix programmed with QjS RNA and TCA precipitated as de­
scribed. The arrows indicate the position of migration of the 
fluorescein-labeled molecular weight standards cytochrome c (left 
arrow, molecular weight 12,500 daltons) and myoglobin (right 
arrow, molecular weight 17,000 daltons). (B) is the electrophoretic 
pattern of an equal aliquot of the reaction mix used In (A), but 
precipitated with antibody directed against purified Q/3 coat protein. 
The peak of radioactivity seen in (A) and (B) migrates at the position 
of Q/3 coat protein. The amount of radioactivity in the peak at the 
Qfi coat position in (A) and (B) is identical. (C) and (D) are analo­
gous to (A) and (B). except that the reaction mixture was pro­
grammed with GB11 RNA and a saturating level (10 pg per 50 
pi reaction) of purified E. coli tyrosine suppressor tRNA. The peaks 
in (C) and (D) have identical amounts of radioactivity.
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